Barr Pharmaceuticals Financial Market Data
| Last Close 14-Aug-2008 |
$67.57 |
Price/ Sales Ratio |
2.90 |
| 52-Week High |
$68.15 |
Price/ Book Ratio |
3.55 |
| 52-Week Low |
$37.40 |
Price/ Earnings Ratio |
51.52 |
| 60-Month Beta |
0.4 |
Price/ Cash Flow Ratio |
20.71 |
| Market Cap (mil.) |
$7,317.5 |
Return on Assets |
0.0% |
| Shares Outstanding (mil.) |
108.3 |
Return on Equity |
0.0% |
| Dividend Rate |
-- |
Current Ratio |
2.20 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
1.00 |
| # of Institutional Holders |
408 |
% Owned by Institutions |
82.0% |
| Latest Short Interest Ratio |
0.79 |
Latest Net Insider Transactions |
11,297.00 |
| Revenue Growth |
0.0% |
0.0% |
0.0% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
